BVAC-B vaccine (Cellid)

N/A

Report date: 2024/05/13 20:00:33

Base Information

Drug NameBVAC-B vaccine (Cellid)
Drug Alias NameBVAC-B
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHelper-inducer T-lymphocytes stimulantsCytotoxic T lymphocytes stimulantsNKT cells stimulants +[5] 
TargetsT-cell receptorReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellid Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellid Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A